FDA Adverse Event Malfunction Summary report: N

ACTIVA

MDR report key: 5188097 · Received October 29, 2015

Report

Report Number
3007566237-2015-03138
Event Type
Malfunction
Date Received
October 29, 2015
Report Date
October 6, 2015
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID 7426, SERIAL# (B)(4), IMPLANTED: (B)(6) 2007, EXPLANTED: (B)(6) 2015, PRODUCT TYPE IMPLANTABLE NEUROSTIMULATOR. PRODUCT ID 7482, SERIAL# (B)(4), IMPLANTED: (B)(6) 2007, EXPLANTED: (B)(6) 2015, PRODUCT TYPE EXTENSION. (B)(4).

Description of Event or Problem · 1

A HEALTH CARE PROVIDER (HCP) REPORTED VIA A MANUFACTURING REPRESENTATIVE THAT IN 2014 THE PATIENT HAD LESS DEEP BRAIN STIMULATION (DBS) EFFECT. RECENTLY A FRACTURE IN THE SYSTEM WAS SUSPECTED DUE TO UNSTABLE IMPEDANCES. ABNORMAL IMPEDANCES WERE MEASURED AND PRIOR TO THE REVISION, IMPEDANCES OF ELECTRODE THREE ON THE LEFT SIDE WAS UNSTABLE. THE IMPEDANCES VALUES IMPLIED A SHORT OR A FRACTURE. THERE WERE NO SUSPICIOUS FINDINGS ON X-RAYS. A REVISION TO REPLACE THE EXTENSION AND IMPLANTABLE NEUROSTIMULATOR (INS) WAS DONE. DURING THE REVISION, BLOOD WAS FOUND TO BE MIXED IN THE UPPER PORTION OF THE INS WERE ELECTRODES 0-3 WERE LOCATED AND ONLY A HALF OF THE BOOT WAS COVERING THE LEAD AND ADAPTOR. AFTER THE REVISION, IMPEDANCES OF ELECTRODE ZERO WERE MEASURED TO BE HIGH. THE CAUSE OF THE HIGH IMPEDANCES, NO INTERVENTIONS, AND NO OUTCOME WAS REPORTED REGARDING THIS EVENT. FURTHER FOLLOW-UP IS BEING CONDUCTED TO OBTAIN THIS INFORMATION. IF ADDITIONAL INFORMATION IS RECEIVED, A FOLLOW UP REPORT WILL BE SENT. REFER TO MANUFACTURER REPORT #9614453-2015-02686.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
719636 ACTIVA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC NEUROMODULATION 37602

Patients

Seq Age Sex Outcome Treatment
1